Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Events entities : Abbvie inc. save search
AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: -1.92%
H: 0.0%
C: 0.0%
qulipta abbvie treatment for migraine
AbbVie to Present at the Barclays 26th Annual Global Healthcare Conference
Published: 2024-03-07 (Crawled : 15:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 0.62%
H: 0.13%
C: -0.89%
conference abbvie global
AbbVie to Host Third-Quarter 2023 Earnings Conference Call
Published: 2023-10-04 (Crawled : 13:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
conference abbvie
AbbVie to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
Published: 2023-06-06 (Crawled : 15:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 0.45%
H: 0.05%
C: -1.48%
conference abbvie global
AbbVie to Present at the Bank of America Securities Healthcare Conference
Published: 2023-05-02 (Crawled : 13:20) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: -0.1%
H: 0.96%
C: -1.26%
america conference abbvie
AbbVie to Present at the Barclays Global Healthcare Conference - March 8, 2023
Published: 2023-03-08 (Crawled : 14:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: -0.09%
H: 0.62%
C: -2.09%
global conference abbvie
AbbVie Highlights Robust Gastroenterology Portfolio with New Analyses and Data in Inflammatory Bowel Diseases at the 18th Congress of European Crohn's and Colitis Organisation (ECCO)
Published: 2023-02-27 (Crawled : 14:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 0.36%
H: 0.97%
C: 0.67%
abbvie
AbbVie Braves Humira LOE, Remains Confident in Long-Term Growth
Published: 2023-01-11 (Crawled : 12:20) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: -0.26%
H: 0.08%
C: -1.29%
abbvie humira growth
AbbVie Highlights Robust Gastroenterology Portfolio with New Data in Crohn's Disease and Ulcerative Colitis at the UEG Week 2022
Published: 2022-09-29 (Crawled : 12:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 0.17%
H: 0.28%
C: -1.47%
disease week ulcerative colitis
AbbVie Announces Public Voting Open for 30th Annual Cystic Fibrosis Scholarship "Thriving Student Awards"
Published: 2022-09-14 (Crawled : 16:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 0.46%
H: 0.91%
C: 0.27%
fibrosis cystic fibrosis
AbbVie Showcases New Analyses and Real-World Data Across Multiple Immune-Mediated Skin Diseases at the European Academy of Dermatology and Venereology (EADV) 2022 Congress
Published: 2022-08-29 (Crawled : 13:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: -0.11%
H: 0.38%
C: -0.36%
skin
AbbVie to Present at the Bernstein 38th Annual Strategic Decisions Conference
Published: 2022-05-25 (Crawled : 13:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 2.29%
H: 1.75%
C: 1.06%
conference
AbbVie Showcases its Leadership in Rheumatology Research with New Data Across Multiple Inflammatory Joint Diseases at the EULAR 2022 Congress
Published: 2022-05-24 (Crawled : 14:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: -3.09%
H: 0.0%
C: 0.0%
research disease
Allergan, an AbbVie Company, to Present New Data from its Leading Portfolio of Eye Care Treatments at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Published: 2022-04-28 (Crawled : 13:20) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
care research eye
AbbVie to Showcase Breadth of Neuroscience Portfolio and Pipeline at American Academy of Neurology (AAN) 2022 Annual Meeting
Published: 2022-03-29 (Crawled : 18:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 0.63%
H: 0.18%
C: -0.5%
AbbVie and Allergan Aesthetics to Present New Research Across Dermatology Portfolio at 2022 AAD Annual Meeting
Published: 2022-03-21 (Crawled : 14:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 0.47%
H: 0.63%
C: 0.06%
aesthetic derm research
AbbVie to Present at the Cowen 42nd Annual Health Care Conference
Published: 2022-03-01 (Crawled : 14:30) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
health conference
AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021
Published: 2021-11-01 (Crawled : 14:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 2.72%
H: 0.41%
C: -0.38%
research
AbbVie to Host Third-Quarter 2021 Earnings Conference Call
Published: 2021-10-05 (Crawled : 13:15) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 0.61%
H: 1.09%
C: 0.11%
conference
AbbVie to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
Published: 2021-06-02 (Crawled : 14:00) - biospace.com/
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: 0.18%
H: 0.22%
C: -0.9%
conference
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M
|
AGBA | $2.74 119.2% 52M
|
Finance
CZOO | $9.07 81.76% 22M
|
EDBL | News | $6.56 74.47% 1.8M
|
MTC | $2.21 41.67% 5.6M
|
Technology Services
OPRT | News | $3.12 38.67% 11M
|
Finance
PALI | $6.59 33.67% 23M
|
Manufacturing
VNRX | $0.7945 32.42% 3.1M
|
Health Technology
MLEC | $1.81 29.29% 2.8M
|
n/a
BTCM | $3.45 27.78% 640K
|
Arts, Entertainment, and Recrea...
Your saved searches
Save your searches and get alerts when important news are released.